Buy HUL, Dabur, Sun Pharma: Sudarshan Sukhani

Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "I am sticking with the safety. Hindustan Unilever (HUL) is making base pattern that we want for the Nifty to do. It is already doing that, it is choppy because the Nifty is choppy. I would be a buyer; I think it is probably bottoming out otherwise also." "Dabur has the same story. It is building a small base, not visibly large but it is still there. Surprisingly FMCG is now giving us that theme that a correction is getting over. So, Dabur is a buying opportunity. Like HUL, Dabur is also a positional buy. So far as this upswing continues, so far as we are in choppy waters, even choppy markets will see upmoves and down moves. So, you stay with the long side, day trades as well as positional," he said. "Sun Pharmaceutical Industries is already in an upswing. It is not necessary that all stocks bottom out with the Nifty. Sun Pharmaceutical had a bear market of its own and bottomed out much earlier. That upswing is valid. While volatile moves on Friday should be ignored as a one day move, I think that uptrend is likely to continue.""We are sticking with safety – HUL, Dabur, Sun Pharmaceutical. All three are positional trades, apart from day trades."